Epoetin dosing and dialysis facility ownership

JAMA. 2007 Aug 22;298(8):862; author reply 862-3. doi: 10.1001/jama.298.8.862-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Ambulatory Care Facilities* / organization & administration
  • Anemia / drug therapy
  • Anemia / etiology
  • Epoetin Alfa
  • Erythropoietin / therapeutic use*
  • Hematinics / therapeutic use*
  • Hematocrit
  • Hemoglobins / metabolism
  • Humans
  • Ownership
  • Recombinant Proteins
  • Renal Dialysis* / adverse effects
  • Renal Dialysis* / standards
  • Renal Insufficiency, Chronic / blood
  • Renal Insufficiency, Chronic / therapy*
  • United States

Substances

  • Hematinics
  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin
  • Epoetin Alfa